$CTOR - Pharma8k's

11 Dec 2025 SEC Filing 8-K $CTOR

Citius Oncology (CTOR) Secures $18 Million Financing Following FDA Approval of LYMPHIR

Citius Oncology (CTOR) closed an $18 million offering after FDA approval of its CTCL drug LYMPHIR, per an 8-K filed Dec 10, 2025.